These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37173453)

  • 1. Relationship between gut microbiome Fusobacterium nucleatum and LINE-1 methylation level in esophageal cancer.
    Baba Y; Hara Y; Toihata T; Kosumi K; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Komohara Y; Baba H
    Esophagus; 2023 Oct; 20(4):704-712. PubMed ID: 37173453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis.
    Yamamura K; Baba Y; Nakagawa S; Mima K; Miyake K; Nakamura K; Sawayama H; Kinoshita K; Ishimoto T; Iwatsuki M; Sakamoto Y; Yamashita Y; Yoshida N; Watanabe M; Baba H
    Clin Cancer Res; 2016 Nov; 22(22):5574-5581. PubMed ID: 27769987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
    Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
    Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
    Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis.
    Sakamoto Y; Mima K; Ishimoto T; Ogata Y; Imai K; Miyamoto Y; Akiyama T; Daitoku N; Hiyoshi Y; Iwatsuki M; Baba Y; Iwagami S; Yamashita YI; Yoshida N; Komohara Y; Ogino S; Baba H
    Cancer Sci; 2021 Nov; 112(11):4470-4477. PubMed ID: 34464993
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
    Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Hamada T; Zhang X; Mima K; Bullman S; Sukawa Y; Nowak JA; Kosumi K; Masugi Y; Twombly TS; Cao Y; Song M; Liu L; da Silva A; Shi Y; Gu M; Li W; Koh H; Nosho K; Inamura K; Keum N; Wu K; Meyerhardt JA; Kostic AD; Huttenhower C; Garrett WS; Meyerson M; Giovannucci EL; Chan AT; Fuchs CS; Nishihara R; Giannakis M; Ogino S
    Cancer Immunol Res; 2018 Nov; 6(11):1327-1336. PubMed ID: 30228205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Fecal
    Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
    Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue.
    Mehta RS; Nishihara R; Cao Y; Song M; Mima K; Qian ZR; Nowak JA; Kosumi K; Hamada T; Masugi Y; Bullman S; Drew DA; Kostic AD; Fung TT; Garrett WS; Huttenhower C; Wu K; Meyerhardt JA; Zhang X; Willett WC; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
    JAMA Oncol; 2017 Jul; 3(7):921-927. PubMed ID: 28125762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients.
    Boehm ET; Thon C; Kupcinskas J; Steponaitiene R; Skieceviciene J; Canbay A; Malfertheiner P; Link A
    Sci Rep; 2020 Oct; 10(1):16240. PubMed ID: 33004953
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
    Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
    Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Yamamura K; Baba Y; Miyake K; Nakamura K; Shigaki H; Mima K; Kurashige J; Ishimoto T; Iwatsuki M; Sakamoto Y; Yamashita Y; Yoshida N; Watanabe M; Baba H
    Oncol Lett; 2017 Dec; 14(6):6373-6378. PubMed ID: 29151903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A newly developed PCR-based method revealed distinct Fusobacterium nucleatum subspecies infection patterns in colorectal cancer.
    Bi D; Zhu Y; Gao Y; Li H; Zhu X; Wei R; Xie R; Wei Q; Qin H
    Microb Biotechnol; 2021 Sep; 14(5):2176-2186. PubMed ID: 34309194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway.
    Nomoto D; Baba Y; Liu Y; Tsutsuki H; Okadome K; Harada K; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Moroishi T; Komohara Y; Sawa T; Baba H
    Cancer Lett; 2022 Apr; 530():59-67. PubMed ID: 35033591
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.